Wataru Nogami

Affiliations

Pharmaceutical Research Division, Shionogi & Co., Ltd., 561-0825 Osaka, Japan.

Réseau de co-auteurs

Azumi Ueyama 2 collaborations

Mai Yoshikawa 2 collaborations

Tetsuya Yoshida 2 collaborations

Satomi Shinonome 2 collaborations

Hiroshi Yoshida 2 collaborations

Michinari Hirata 2 collaborations

Miya Haruna 2 collaborations

Hisashi Wada 2 collaborations

Naganari Ohkura 2 collaborations

Yujiro Kidani 1 collaboration

Yoshiaki Yasumizu 1 collaboration

Atsunari Kawashima 1 collaboration

Atsushi Tanaka 1 collaboration

Yudai Sonoda 1 collaboration

Yumi Tona 1 collaboration

Kunitaka Nashiki 1 collaboration

Reimi Matsumoto 1 collaboration

Masaki Hagiwara 1 collaboration

Motonao Osaki 1 collaboration

Keiji Dohi 1 collaboration

Takayuki Kanazawa 1 collaboration

Mitsunobu Matsumoto 1 collaboration

Kanji Hojo 1 collaboration

Yamami Nakamura 1 collaboration

Daisuke Motooka 1 collaboration

Daisuke Okuzaki 1 collaboration

Yasuko Sugiyama 1 collaboration

Makoto Kinoshita 1 collaboration

Tatsusada Okuno 1 collaboration

Taigo Kato 1 collaboration

Koji Hatano 1 collaboration

Motohide Uemura 1 collaboration

Ryoichi Imamura 1 collaboration

Kazunori Yokoi 1 collaboration

Atsushi Tanemura 1 collaboration

Yasushi Shintani 1 collaboration

Tadashi Kimura 1 collaboration

Norio Nonomura 1 collaboration

Masaki Mori 1 collaboration

Yuichiro Doki 1 collaboration

Shimon Sakaguchi 1 collaboration

Yoji Nagira 1 collaboration

Morio Nagira 1 collaboration

Ryohei Nagai 1 collaboration

Hiroto Miwa 1 collaboration

Natsumi Chatani 1 collaboration

Hidekazu Tanaka 1 collaboration

Wataru Nogami

Affiliations

Publications (2)

CCR8-targeted specific depletion of clonally expanded Treg cells in tumor tissues evokes potent tumor immunity with long-lasting memory.

S-531011, a Novel Anti-Human CCR8 Antibody, Induces Potent Antitumor Responses through Depletion of Tumor-Infiltrating CCR8-Expressing Regulatory T Cells.

Réseau de co-auteurs